Glaucoma Flashcards
Types of Glaucoma
Primary (POAG vs PCAG)
Secondary
Primary glaucoma
No underlying cause identified
Further broken down into
- Primary Open Angle Glaucoma (POAG)
- Primary Angle closure Glaucoma (PACG)
Secondary Glaucoma
Due to identifiable cause: HTN, diabetes, Trauma
Primary Open Angle Glaucoma
Most common
Angle between Iris and cornea= open and normal
Increased IOP from resistance to drainage of AH via trabecular network
Primary Angle Closure glaucoma
Angle between iris and cornea narrows—> prevents drainage of aqueous fluid
Acute PACG
Sudden rise in IOP ( ≥ 30mmHg)
Medical emergency that can result in vision loss
Sx of acute PACG
Pain
Headache
Nausea
Vomiting
Blurry vision
Halos around lights
Chronic PACG
Asymptomatic
Gradual progression of optic nerve damage
Risk factors for POAG (4)
FmDx
Age >40
Race—> AA
Elevated IOP (>21mmHg= increased risk)
Medications that exacerbate or induce glaucoma (5)
Glucocorticoids
Anticholinergics
TCAs
First Gen Anhistamines
Decongestants
How do medications with an antcholinergic effect cause glaucoma?
Anticholinergics produce pupillary dilation—> angle between iris and cornea narrow—> increased IOP
What population should avoid use of medications with anticholinergic effects due to the risk of glaucoma?
Patients with PACG
What Anticholinergics (specifically) induce glaucoma?
Scopolamine
Benztropine
Trihexphenidyl
Treatment of choice for Chronic PACG
Laser Iridotomy
Treatment options for glaucoma
Pharmacotherapy
Laser therapy
Surgical intervention
Laser Iridotomy—> 1st line chronic PACG
When may the target IOP be lower?
When the patient has disease progression of glaucoma despite IOP lowering
T/F: decreases IOP treats/cures glaucoma
False
Decreasing IOP helps prevent and slow progression
Goal of glaucoma treatment
Decrease IOP to help prevent/reduce disease progression
How can medications accomplish reduction of IOP?
Decreasing aqueous fluid production
Increasing Aqueous fluid outflow
What is the initial goal for IOP reduction?
20-50%
Agents that DECREASE FLUID PRODUCTION
Β Blockers- 1st line
𝛼 Adrenergic Agonists - 2nd line
Carbonic Anhydrase inhibitors
— topical- 2nd line
— systemic- 3rd line
Meds that decrease fluid production MNEUMONIC
BAC T2S3
Agents that INCREASE FLUID OUTFLOW
Prostaglandin Analogs (PG)- 1st line
𝛼 2 adrenergic agonists- 2nd line
Cholinergic agonists- 3rd line
Rho Kinase Inhibitors (ROCK inhibitors)
What is the first line agent in DECREASING AQUEOUS FLUID PRODUCTION?
Β Blockers